Zepbound, a tirzepatide-based medication approved in 2023 for weight loss, offers similar benefits and might be considered in your treatment plan
Many people discover they eat significantly less than they think on GLP-1 therapy
Other well-established risk factors for vulvovaginal candidiasis, according to the British Association for Sexual Health and HIV (BASHH) guidelines, include recent antibiotic use, pregnancy, immunosuppression (including high-dose corticosteroids), and certain contraceptives
Long-Term Outcomes: While existing trials show robust weight loss over ~64 weeks, real-world effectiveness and durability of oral semaglutide for weight management will require ongoing observation
Start your intake How Tirzepatide Affects Your Digestive System Tirzepatide activates two hormone receptors in your gut: GLP-1 and GIP
If you prefer products backed by human trials and research transparency Tonum emphasizes evidence and clear labeling across its products